Recombinant Human IMP1/IMPA1 Protein (His Tag) | PKSH030519

(No reviews yet) Write a Review
SKU:
575-PKSH030519
€1,120.00
Frequently bought together:

Description

Recombinant Human IMP1/IMPA1 Protein (His Tag) | PKSH030519 | Gentaur US, UK & Europe Disrtribition

Synonyms: Inositol Monophosphatase 1; IMP 1; IMPase 1; Inositol-1(or 4)-Monophosphatase 1; Lithium-Sensitive Myo-Inositol Monophosphatase A1; IMPA1; IMPA

Active Protein: N/A

Activity: A DNA sequence encoding the human IMPA1 (P29218-1) (Met1-Asp277) was expressed with a polyhistidine tag at the N-terminus.

Protein Construction: A DNA sequence encoding the human IMPA1 (P29218-1) (Met1-Asp277) was expressed with a polyhistidine tag at the N-terminus.

Fusion Tag: N-His

Species: Human

Expressed Host: E.coli

Shipping: This product is provided as lyophilized powder which is shipped with ice packs.

Purity: > 85 % as determined by reducing SDS-PAGE.

Endotoxin: Please contact us for more information.

Stability and Storage: Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80℃. Reconstituted protein solution can be stored at 4-8℃ for 2-7 days. Aliquots of reconstituted samples are stable at < -20℃ for 3 months.

Molecular Mass: 32.4 kDa

Formulation: Lyophilized from sterile PBS, 10 % glycerol, pH 7.4

Reconstitution: Please refer to the printed manual for detailed information.

Background: The IMPA1 gene product is responsible for the final step of biotransformation of inositol triphosphate and diacylglycerol, two second messengers. Despite its many physiological functions, no clinical phenotype has been assigned to this gene dysfunction to date. Additionally, IMPA1 is the main target of lithium, a drug that is at the forefront of treatment for bipolar disorder.

Research Area: N/A

View AllClose